Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium for Fracture Treatment
NCT02999022Phase 2Recruiting
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Jul 2017
- Primary completion
- Dec 2024
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in bone fracture comparing Lithium carbonate with Lactose placebo (2 arms). Primary endpoint: Radiographic healing of fracture at 8 weeks. Started Jul 2017; status: recruiting.
02
Drugs
lithium carbonate
03
Conditions
bone fracture
Beyond the preview
Go deeper on NCT02999022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02999022.